Meet NanoTemper’s New Executive Leadership Team
NanoTemper Introduces New Executive Leadership Team to Advance Biophysical Innovation
The Future of Molecular Analysis: Dr Stefan Duhr on NanoTemper’s Single-Molecule Vision
NanoTemper Strengthens Biopharma Discovery Portfolio with Acquisition of Envue Technologies and Launch of Dianthus™ α
NanoTemper Announces Leadership Evolution: Philipp Baaske Transitions to Executive Chairman
NanoTemper Technologies unveils Dianthus uHTS — the fastest biophysical method on the market
NanoTemper Technologies Establishes Advisory Board to Propel Innovation and Growth
NanoTemper brings Spectral Shift technology to the protein production market with Andromeda X, enabling biopharma and CROs
5 considerations for buffer optimization during biologics pre-formulation